CFO Greg Hunter Appointed Interim CEO at MediPharm Labs

*TORONTO* — David Pidduck will step down from his role as MediPharm Labs
Corp.’s chief executive officer effective January 23. The Board of
Directors has appointed Greg Hunter, the company’s chief financial officer
interim chief executive officer while it evaluates long‑term leadership
plans. Hunter will continue to serve as CFO.

Pidduck will continue to serve on the board to ensure a seamless transition.

Since assuming the CFO role in February 2021, Hunter has implemented
meaningful cost‑reduction initiatives and strengthened financial and
operational controls. He has also been deeply involved in commercial
strategy, working closely with the sales, marketing, and product teams to
enhance pricing, support key customer programs, negotiate improved
commercial terms, and ensure manufacturing and supply capabilities align
with market demand.

In addition to his financial background, Hunter also brings broad
commercial, operational, and general management experience, gained over
more than 20 years in cross-functional leadership roles at global Fortune
500 organizations such as Johnson & Johnson and Baxter, as well as private
equity portfolio companies.